CABA
Price
$1.69
Change
+$0.15 (+9.74%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
140.86M
68 days until earnings call
GBIO
Price
$6.03
Change
+$0.25 (+4.33%)
Updated
Sep 5, 04:58 PM (EDT)
Capitalization
40.35M
61 days until earnings call
Interact to see
Advertisement

CABA vs GBIO

Header iconCABA vs GBIO Comparison
Open Charts CABA vs GBIOBanner chart's image
Cabaletta Bio
Price$1.69
Change+$0.15 (+9.74%)
Volume$12.75K
Capitalization140.86M
Generation Bio
Price$6.03
Change+$0.25 (+4.33%)
Volume$344
Capitalization40.35M
CABA vs GBIO Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. GBIO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and GBIO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CABA: $1.54 vs. GBIO: $5.78)
Brand notoriety: CABA and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 173% vs. GBIO: 29%
Market capitalization -- CABA: $140.86M vs. GBIO: $40.35M
CABA [@Biotechnology] is valued at $140.86M. GBIO’s [@Biotechnology] market capitalization is $40.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while GBIO’s TA Score has 3 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 6 bearish.
  • GBIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CABA and GBIO are a bad buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а +2.67% price change this week, while GBIO (@Biotechnology) price change was -6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

CABA is expected to report earnings on Nov 12, 2025.

GBIO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($141M) has a higher market cap than GBIO($40.3M). CABA YTD gains are higher at: -32.159 vs. GBIO (-45.472). GBIO has higher annual earnings (EBITDA): -69.92M vs. CABA (-140.83M). CABA has more cash in the bank: 195M vs. GBIO (141M). CABA has less debt than GBIO: CABA (24.9M) vs GBIO (85.3M). GBIO has higher revenues than CABA: GBIO (21.2M) vs CABA (0).
CABAGBIOCABA / GBIO
Capitalization141M40.3M350%
EBITDA-140.83M-69.92M201%
Gain YTD-32.159-45.47271%
P/E RatioN/AN/A-
Revenue021.2M-
Total Cash195M141M138%
Total Debt24.9M85.3M29%
FUNDAMENTALS RATINGS
CABA: Fundamental Ratings
CABA
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABAGBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 15 days ago
87%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWLIF0.190.01
+6.15%
AMERIWEST CRITICAL METALS INC.
HKHHF68.920.48
+0.70%
Heineken Holding N.V.
CCTSF11.79N/A
N/A
Cactus Acquisition Corp. 1 Limited
EUBG0.30N/A
N/A
ENTREPRENEUR UNIVERSE BRIGHT GROUP
UMICY3.82-0.02
-0.39%
Umicore SA

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-1.91%
IPSC - CABA
52%
Loosely correlated
+2.26%
ARWR - CABA
48%
Loosely correlated
+0.72%
GBIO - CABA
47%
Loosely correlated
-3.34%
KYTX - CABA
45%
Loosely correlated
-2.42%
ARCT - CABA
45%
Loosely correlated
-2.50%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-3.34%
CABA - GBIO
47%
Loosely correlated
-1.91%
MGNX - GBIO
45%
Loosely correlated
+1.57%
OVID - GBIO
43%
Loosely correlated
-3.01%
SYRE - GBIO
43%
Loosely correlated
+1.07%
FATE - GBIO
42%
Loosely correlated
-2.71%
More